The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity
about
Cancer as a Proinflammatory Environment: Metastasis and CachexiaTumor necrosis factor links chronic obstructive pulmonary disease and K-ras mutant lung cancer through induction of an immunosuppressive pro-tumor microenvironmentA multi-targeted approach to suppress tumor-promoting inflammationCombined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapyProteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis.Endotoxin-induced tumor necrosis factor alpha synthesis in murine embryo fibroblasts.Evaluation of F8-TNF-α in Models of Early and Progressive Metastatic Osteosarcoma.Chronic inflammation and cytokines in the tumor microenvironment.Roles for tumor necrosis factor and gamma interferon in resistance to enteric listeriosisEffect of tumour necrosis factor and lipid A on functional and structural vascular volume in solid murine tumoursTranscriptional control of viral gene therapy by cisplatinTargeting the tumor microenvironment to enhance antitumor immune responsesRole of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice.Cardamonin sensitizes tumour cells to TRAIL through ROS- and CHOP-mediated up-regulation of death receptors and down-regulation of survival proteins.Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumorsThe effect of adrenalectomy and dexamethasone on interleukin-1 alpha induced responses in RIF-1 tumoursClostridial spores for cancer therapy: targeting solid tumour microenvironmentTumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transferIn vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumorThe antitumor function of tumor necrosis factor (TNF) II. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma.Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity.Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5).Glucocorticoid-mediated inhibition of endotoxin-induced intratumor tumor necrosis factor production and tumor hemorrhagic necrosis and regression.Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis.Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature.Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer.TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation.Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in miceLong-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity.Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.Role of TLR2-dependent inflammation in metastatic progression.Induced transgene expression for the treatment of solid tumors by hematopoietic stem cell-based gene therapy.Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatinIFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.Nanotherapeutics for enhancing thermal therapy of cancer.Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters.Augmentation of tumor necrosis factor family-induced apoptosis by E3330 in human hepatocellular carcinoma cell lines via inhibition of NF kappa B.Antibody-targeted drugs for the therapy of cancer.Cancer vaccines: the perspective of the Cancer Immunology Branch, NCI.Interleukin-1: therapeutic potential for solid tumors.
P2860
Q26778324-32713548-CB7F-4547-9D6F-774F9EC1E77DQ28392873-2879E3D1-E70D-4533-84D6-FAD5ED02283CQ28393278-4A081387-EBD1-43E3-94A3-278F40FFACEBQ30586812-61108A67-5256-4898-90C1-FA634BFCB537Q33547651-EEBDB0BE-E778-49F4-8D38-3A609BDFB932Q33594509-E01B1EF2-25AE-4B9A-B88D-7CA99638764BQ33607479-1B4B3A2A-82A8-4ECA-8C68-53360452BAE3Q33678275-17E5B782-3C68-4016-A269-AE666DDA6FB9Q33754115-DED652B5-D577-487A-BCBD-C32545E40F93Q34208904-10901627-E314-4A48-9D6E-F0ACDC89AD45Q34795177-C5CE201E-2C34-4401-8EB9-A6C665B5CA94Q35176307-0DA0B3B5-7EC3-40C5-8535-7BE156BDDA0EQ35408288-640B62D7-A69A-4C41-8447-A93FAAAF24A7Q35859789-58655625-2059-469A-9886-0A7E4B4412D7Q35945218-B1B538A9-770B-43AF-9B48-DAEF2643598EQ35981458-0574DE00-885C-477A-BEC6-3920FCF32D84Q36037633-C99C596C-D3D5-49B7-AACC-028C7B7D5D30Q36230110-A58397D7-E224-485E-81AF-3F615F8C2A0CQ36238339-2EEB0A91-AB13-481F-9F3C-37D79A305BE2Q36354727-F0CFB39E-7547-4CD6-8199-F3907FB80E99Q36355720-4DD62DC6-1A98-4CC3-8412-BE6DDBA73F1FQ36355753-D2983FC8-3623-4A72-81A9-204ACC71D3AAQ36356755-2FE2CC0C-624F-4CF7-B0C2-65B36DBF99BAQ36361923-1C746645-6333-42F2-9757-104274F19585Q36566561-EB66693C-D00D-4C81-ADD4-A9DBE0F229D1Q36671593-7A9D0F92-4B08-4883-B2BA-E42251CCE8D3Q36809157-4C124DC7-E4F2-4779-8EF3-D5F6AA8585A2Q37147228-D860A79F-975C-457E-9B03-D26C63F3A7C2Q37490593-12223C48-16E2-435A-93AD-08C0D9502DF3Q37599151-4DA01280-E6DF-4F3B-8A78-5C262AEA4C5BQ37833132-F976D27E-1E2A-45BE-AD50-14BEAAEA7E8CQ39382972-F3CAF0FD-7FE4-413D-8336-3B7133841215Q39710105-6058F374-25CB-4523-A72E-DAE561E24C6EQ40006095-F484946A-5613-4C3A-AAA3-F1A8C531DF4BQ40063990-9AD418BE-BAA9-45C4-90B9-869CBF16430CQ40101284-95E0025B-23FA-4D5C-A94B-40675E78F5C5Q40328271-87E5BC7C-11D7-4A10-8F2A-2D0C94E6B937Q40563987-8E640CCC-0E86-455F-A5FF-DAEE77A88652Q40844506-A0A5C13A-20A4-4D8E-AFE2-73983D314FD5Q40860960-20404E68-19C4-4B91-A89A-8C453B6F6D1E
P2860
The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
The antitumor function of tumo ...... and limited by severe toxicity
@ast
The antitumor function of tumo ...... and limited by severe toxicity
@en
type
label
The antitumor function of tumo ...... and limited by severe toxicity
@ast
The antitumor function of tumo ...... and limited by severe toxicity
@en
prefLabel
The antitumor function of tumo ...... and limited by severe toxicity
@ast
The antitumor function of tumo ...... and limited by severe toxicity
@en
P2093
P2860
P356
P1476
The antitumor function of tumo ...... and limited by severe toxicity
@en
P2093
P2860
P304
P356
10.1084/JEM.167.3.1067
P407
P577
1988-03-01T00:00:00Z